AAAAAA

   
Results: 1-17 |
Results: 17
HEMOSTASIS IN PATIENTS WITH MALIGNANT DISEASE - TREATMENT-RELATED EFFECTS
Authors: BRUHN HD ZURBORN KH
Citation: Hd. Bruhn et Kh. Zurborn, HEMOSTASIS IN PATIENTS WITH MALIGNANT DISEASE - TREATMENT-RELATED EFFECTS, Tumordiagnostik & Therapie, 19(2), 1998, pp. 25-34
DUCKERT,FRANCOIS,HENRI, 1922-1998 - OBITUARY
Authors: BRUHN HD MARBET GA
Citation: Hd. Bruhn et Ga. Marbet, DUCKERT,FRANCOIS,HENRI, 1922-1998 - OBITUARY, Thrombosis and haemostasis, 79(5), 1998, pp. 5-6
HYPERTHERMIC FIBRINOLYSIS WITH RT-PA - IN-VITRO RESULTS
Authors: SCHWARZENBERG H MULLERHULSBECK S BROSSMAN J GLUER CC BRUHN HD HELLER M
Citation: H. Schwarzenberg et al., HYPERTHERMIC FIBRINOLYSIS WITH RT-PA - IN-VITRO RESULTS, Cardiovascular and interventional radiology, 21(2), 1998, pp. 142-145
DUCKERT,FRANCOIS,HENRI - IN-MEMORIAM
Authors: BRUHN HD MARBET GA
Citation: Hd. Bruhn et Ga. Marbet, DUCKERT,FRANCOIS,HENRI - IN-MEMORIAM, Schweizerische medizinische Wochenschrift, 128(20), 1998, pp. 791-792
ACTIVATED PROTEIN-C RESISTANCE - SIGNIFIC ANCE, DIAGNOSIS AND THERAPEUTIC IMPLICATIONS
Authors: BRUHN HD
Citation: Hd. Bruhn, ACTIVATED PROTEIN-C RESISTANCE - SIGNIFIC ANCE, DIAGNOSIS AND THERAPEUTIC IMPLICATIONS, Der Internist, 39(5), 1998, pp. 534-535
ANTICOAGULATION IN TRANSITORY ISCHEMIC AT TACKS FOLLOWING BYPASS-SURGERY
Authors: BRUHN HD
Citation: Hd. Bruhn, ANTICOAGULATION IN TRANSITORY ISCHEMIC AT TACKS FOLLOWING BYPASS-SURGERY, Deutsche Medizinische Wochenschrift, 122(7), 1997, pp. 210-210
MULTICENTER EVALUATION OF A NEW RECOMBINANT THROMBOPLASTIN REAGENT
Authors: ANKRI A BRUHN HD ENGELHARDT W HAFNER G KELLER F PALARETI G VANWERSCH JWJ ZANDER N
Citation: A. Ankri et al., MULTICENTER EVALUATION OF A NEW RECOMBINANT THROMBOPLASTIN REAGENT, Thrombosis and haemostasis, 1997, pp. 2533-2533
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
ANTICOAGULANT FUCOIDAN FRACTIONS FROM FUCUS-VESICULOSUS INDUCE PLATELET ACTIVATION IN-VITRO
Authors: DURIG J BRUHN T ZURBORN KH GUTENSOHN K BRUHN HD BERESS L
Citation: J. Durig et al., ANTICOAGULANT FUCOIDAN FRACTIONS FROM FUCUS-VESICULOSUS INDUCE PLATELET ACTIVATION IN-VITRO, Thrombosis research, 85(6), 1997, pp. 479-491
THE WHITE CLOT SYNDROME
Authors: BRUHN HD
Citation: Hd. Bruhn, THE WHITE CLOT SYNDROME, Der Internist, 38(5), 1997, pp. 479-480
RISK OF THROMBOEMBOLISM IN PATIENTS WITH INFLAMMATORY DISEASE
Authors: LINS M ZURBORN KH PRIES B BRUHN HD
Citation: M. Lins et al., RISK OF THROMBOEMBOLISM IN PATIENTS WITH INFLAMMATORY DISEASE, Deutsche Medizinische Wochenschrift, 121(27), 1996, pp. 855-859
ANALYSIS OF THE INDIVIDUAL QUALITIES OF O RAL ANTICOAGULATION BY THE RATIO F1+2 INR/
Authors: BRUHN HD ZURBORN KH
Citation: Hd. Bruhn et Kh. Zurborn, ANALYSIS OF THE INDIVIDUAL QUALITIES OF O RAL ANTICOAGULATION BY THE RATIO F1+2 INR/, Deutsche Medizinische Wochenschrift, 120(42), 1995, pp. 1441-1444
MODIFIED TECHNIQUE OF LOCAL RT-PA CATHETE R THROMBOLYSIS
Authors: MULLERHULSBECK S LINK J BROSSMANN J SCHWARZENBERG H GRABENER M HULSBECK A BRUHN HD HELLER M
Citation: S. Mullerhulsbeck et al., MODIFIED TECHNIQUE OF LOCAL RT-PA CATHETE R THROMBOLYSIS, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 163(5), 1995, pp. 424-429
ORAL CONTRACEPTION AND PROTEIN-C DEFICIEN CY
Authors: BRUHN HD
Citation: Hd. Bruhn, ORAL CONTRACEPTION AND PROTEIN-C DEFICIEN CY, Deutsche Medizinische Wochenschrift, 119(31-32), 1994, pp. 1100-1100
PROTHROMBIN FRAGMENT F(1+2) - REPLY
Authors: BRUHN HD
Citation: Hd. Bruhn, PROTHROMBIN FRAGMENT F(1+2) - REPLY, Deutsche Medizinische Wochenschrift, 118(41), 1993, pp. 1504-1504
MEASUREMENT OF PROTHROMBIN FRAGMENT F1+2 FOR MONITORING THE ANTICOAGULANT EFFECT OF PHENPROCOUMON
Authors: BRUHN HD ZURBORN KH
Citation: Hd. Bruhn et Kh. Zurborn, MEASUREMENT OF PROTHROMBIN FRAGMENT F1+2 FOR MONITORING THE ANTICOAGULANT EFFECT OF PHENPROCOUMON, Deutsche Medizinische Wochenschrift, 118(26), 1993, pp. 967-970
TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-IV WITH INTRAVENOUS ILOPROST AND PGE(1) - A RANDOMIZED OPENCONTROLLED-STUDY
Authors: ALTSTAEDT HO BERZEWSKI B BREDDIN HK BROCKHAUS W BRUHN HD CACHOVAN M DIEHM C DORRLER J FRANKE CS DIETER J HACH W HELD K HEPP D HEY D HORSCH A HORSCH S MEINHOVEL K MORL H MULLERWIEFEL H SCHNITKER J SCHULTE KL SEIPEL L SIGEL H TASCHKE C TREESE N TRUBESTEIN G
Citation: Ho. Altstaedt et al., TREATMENT OF PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE FONTAINE STAGE-IV WITH INTRAVENOUS ILOPROST AND PGE(1) - A RANDOMIZED OPENCONTROLLED-STUDY, Prostaglandins, leukotrienes and essential fatty acids, 49(6), 1993, pp. 973-973
Risultati: 1-17 |